In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Arabinoside, Cytosine Drug Master File in Korea (Arabinoside, Cytosine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Arabinoside, Cytosine. The MFDS reviews the Arabinoside, Cytosine KDMF as part of the drug registration process and uses the information provided in the Arabinoside, Cytosine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Arabinoside, Cytosine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Arabinoside, Cytosine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Arabinoside, Cytosine suppliers with KDMF on PharmaCompass.